stoxline Quote Chart Rank Option Currency Glossary
  
Jin Medical International Ltd. (ZJYL)
2.355  -0.145 (-5.8%)    05-05 11:01
Open: 2.3
High: 2.6
Volume: 13,418
  
Pre. Close: 2.4999
Low: 2.3
Market Cap: 18(M)
Technical analysis
2026-05-05 11:19:03 AM
Short term     
Mid term     
Targets 6-month :  3.18 1-year :  3.72
Resists First :  2.73 Second :  3.18
Pivot price 2.18
Supports First :  2.05 Second :  1.64
MAs MA(5) :  2.29 MA(20) :  2.19
MA(100) :  2.96 MA(250) :  7.9
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  69.9 D(3) :  65.7
RSI RSI(14): 54.4
52-week High :  18 Low :  1.64
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ ZJYL ] has closed below upper band by 19.0%. Bollinger Bands are 52.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.73 - 2.74 2.74 - 2.76
Low: 2.03 - 2.04 2.04 - 2.05
Close: 2.48 - 2.5 2.5 - 2.52
Company Description

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Headline News

Mon, 27 Apr 2026
Director at Jin Medical (ZJYL) submits initial SEC Form 3 - Stock Titan

Fri, 24 Apr 2026
[Form 3] Jin Medical International Ltd. Initial Statement of Beneficial Ownership - Stock Titan

Fri, 24 Apr 2026
Jin Medical International (ZJYL) director files initial Form 3 - Stock Titan

Thu, 23 Apr 2026
ZJYL (JIN) management prioritizes core medical device segment expansion to drive sustained long-term revenue growth. - Regulatory Risk - Cổng thông tin điện tử tỉnh Tây Ninh

Tue, 07 Apr 2026
Jin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share Split - TipRanks

Tue, 07 Apr 2026
Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 7 (M)
Shares Float 1 (M)
Held by Insiders 86.9 (%)
Held by Institutions 0.2 (%)
Shares Short 15 (K)
Shares Short P.Month 14 (K)
Stock Financials
EPS 0.2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.78
Profit Margin 5.7 %
Operating Margin 9.8 %
Return on Assets (ttm) 0.7 %
Return on Equity (ttm) 4.7 %
Qtrly Rev. Growth -16.5 %
Gross Profit (p.s.) 0.91
Sales Per Share 3.02
EBITDA (p.s.) 0.12
Qtrly Earnings Growth -32 %
Operating Cash Flow 3 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio 11.77
PEG Ratio 0
Price to Book value 0.62
Price to Sales 0.77
Price to Cash Flow 5.54
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android